Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $9.4B | -- | -- | -$0.00 | -- |
| 11/06/2025 | Q3 | $9.2B | $9.1B | -$0.06 | -$0.05 | -$0.01 |
| 08/07/2025 | Q2 | $9.8B | $9.8B | $0.63 | -$0.12 | $0.76 |
| 05/08/2025 | Q1 | $9.6B | $9B | -$0.18 | -$0.12 | -$0.07 |
| 02/27/2025 | Q4 | $10.2B | $10B | -$0.20 | $0.16 | -$0.36 |
| 11/07/2024 | Q3 | $9.8B | $9.6B | $0.05 | $0.16 | -$0.10 |
| 08/07/2024 | Q2 | $10.1B | $9.7B | -$4.07 | $0.00 | -$4.08 |
| 05/09/2024 | Q1 | $10.2B | $10B | -$0.40 | -$0.17 | -$0.23 |
| 02/23/2024 | Q4 | $10.4B | $10.3B | -$0.16 | -$0.01 | -$0.15 |
| 11/08/2023 | Q3 | -- | $10B | -$0.17 | -- | -- |
| 06/30/2023 | Q2 | -- | $10.4B | -$0.51 | -- | -- |
| 03/31/2023 | Q1 | -- | $10.7B | -$0.44 | -- | -- |
| 12/31/2022 | Q4 | -- | $11B | -$0.87 | -- | -- |
| 09/30/2022 | Q3 | -- | $9.8B | -$0.95 | -- | -- |
| 06/30/2022 | Q2 | -- | $9.8B | -$1.50 | -- | -- |
| 03/31/2022 | Q1 | -- | $3.2B | $0.69 | -- | -- |
| 12/31/2021 | Q4 | -- | $3.2B | $0.08 | -- | -- |
| 09/30/2021 | Q3 | -- | $3.1B | $0.24 | -- | -- |
| 06/30/2021 | Q2 | -- | $3.1B | $1.01 | -- | -- |
| 03/31/2021 | Q1 | -- | $2.8B | $0.21 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.9B | $0.41 | -- | -- |
| 09/30/2020 | Q3 | -- | $2.6B | $0.44 | -- | -- |
| 06/30/2020 | Q2 | -- | $2.5B | $0.40 | -- | -- |
| 03/31/2020 | Q1 | -- | $2.7B | $0.55 | -- | -- |
| 12/31/2019 | Q4 | -- | $2.9B | $0.67 | -- | -- |
| 09/30/2019 | Q3 | -- | $2.7B | $0.35 | -- | -- |
| 06/30/2019 | Q2 | -- | $2.9B | $1.31 | -- | -- |
| 03/31/2019 | Q1 | -- | $2.7B | $0.53 | -- | -- |
| 12/31/2018 | Q4 | -- | $2.8B | $0.37 | -- | -- |
| 09/30/2018 | Q3 | -- | $2.6B | $0.16 | -- | -- |
| 06/30/2018 | Q2 | -- | $2.8B | $0.29 | -- | -- |
| 03/31/2018 | Q1 | -- | $2.3B | -$0.02 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.9B | -$2.59 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.7B | $0.38 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.8B | $0.62 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.6B | $0.35 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.7B | $0.49 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.6B | $0.35 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.7B | $0.63 | -- | -- |
| 03/31/2016 | Q1 | -- | $1.6B | $0.39 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.6B | $0.32 | -- | -- |
Warner Bros. Discovery, Inc. reported $9.1B worth of top line sales in its most recent quarter.
Warner Bros. Discovery, Inc. announced earnings per share of -$0.06 which represents a miss of analyst forecast a -$0.05 per share.
Warner Bros. Discovery, Inc. reported $3.1B that represents $1.26 per share over the last quarter.
Warner Bros. Discovery, Inc.'s earnings are forecast to decrease from -$4.62 per share to $0.27 per share next year representing a decrease of -94.35%.
Warner Bros. Discovery, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.